Abstract submission deadline November 1, 2019
- Precision In Vivo Genetic Therapies
- Targeting and Delivery Methods for Gene Therapies
- Cell-based Immunotherapies
- Gene Editing, Stem Cells, and Regenerative Medicine
- Overcoming Host Barriers and Immunogenicity
Abstracts received before the abstract deadline will be considered for poster presentations and/or a limited number of oral presentations. If your abstract is accepted, it will be included in our online abstract booklet that will be distributed to all conference participants.
Any abstracts submitted after the deadline will be eligible for poster presentations only. Please also note that we can only allow one abstract per presenting author. Abstracts will not be published and authors also reserve the right to publish their work elsewhere.
All abstracts will be reviewed by the organizers to ensure that the topic of the submission is consistent with the scope of the topics covered at the symposium. A small number of abstracts will be selected for short talks by the organizing committee.
Once the abstract is accepted, at least one of the authors must register for and present at the conference.
A condition of submission is that, if accepted, the poster and/or talk will be presented at the conference by one of the authors.
Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence.
For revisions or queries regarding abstracts already submitted please contact the Publishing Content Coordinator, Arun Gopalakrishnan
If you do not receive acknowledgement for your abstract submission or you wish to make any essential revisions to an abstract already submitted, please do not resubmit your abstract, as this may lead to duplication. Please contact the Conference Content Executive (Please do not email credit card information under any circumstances) with details of any revisions or queries. Please quote your reference number if you have one.